SU6
3-{2,4-dimethyl-5-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid
Find entries where: SU6
is present as a standalone ligand in 2 entries
Chemical Component Summary | |
|---|---|
| Name | 3-{2,4-dimethyl-5-[(Z)-(2-oxo-1,2-dihydro-3H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl}propanoic acid |
| Synonyms | SU6668 |
| Identifiers | 3-[2,4-dimethyl-5-[(Z)-(2-oxidanylidene-1H-indol-3-ylidene)methyl]-1H-pyrrol-3-yl]propanoic acid |
| Formula | C18 H18 N2 O3 |
| Molecular Weight | 310.347 |
| Type | NON-POLYMER |
| Isomeric SMILES | Cc1c(c([nH]c1/C=C\2/c3ccccc3NC2=O)C)CCC(=O)O |
| InChI | InChI=1S/C18H18N2O3/c1-10-12(7-8-17(21)22)11(2)19-16(10)9-14-13-5-3-4-6-15(13)20-18(14)23/h3-6,9,19H,7-8H2,1-2H3,(H,20,23)(H,21,22)/b14-9- |
| InChIKey | NHFDRBXTEDBWCZ-ZROIWOOFSA-N |
Chemical Details | |
|---|---|
| Formal Charge | 0 |
| Atom Count | 41 |
| Chiral Atom Count | 0 |
| Bond Count | 43 |
| Aromatic Bond Count | 11 |
Drug Info: DrugBank
| DrugBank ID | DB12072 |
|---|---|
| Name | Orantinib |
| Groups | investigational |
| Description | Orantinib has been used in trials studying the treatment of Lung Cancer, Breast Cancer, Kidney Cancer, Gastric Cancer, and Prostate Cancer, among others. |
| Synonyms |
|
| Categories |
|
| CAS number | 252916-29-3 |
Related Resource References
| Resource Name | Reference |
|---|---|
| Pharos | CHEMBL274654 |
| PubChem | 5329099 |
| ChEMBL | CHEMBL274654 |
